SAXE JON S 4
4 · VistaGen Therapeutics, Inc. · Filed Mar 22, 2021
Insider Transaction Report
Form 4
SAXE JON S
Director
Transactions
- Exercise/Conversion
Common Stock
2021-03-19$1.50/sh+2,500$3,750→ 5,751 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-03-19−2,500→ 0 totalExercise: $1.50From: 2018-08-29Exp: 2021-04-26→ Common Stock (2,500 underlying)
Holdings
- 50,000(indirect: By Trust)
Common Stock